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There is increasing recognition that chronic low-
grade inflammation is a feature of COPD, however,
there are presently few papers evaluating the
cytokine response to exercise. We were therefore
interested in the stimulating work of van Helvoort
et al.1 and would like to take this opportunity to
raise a few thoughts.
Systemic inflammation, in particular C-reactive
protein is associated with cardiovascular mortality
in healthy subjects2 and early work highlights
possible similarities in COPD.3 van Helvoort et al.1
confirm the presence of raised CRP in COPD and
demonstrate that systemic inflammation (as mea-
sured by circulating leukocytes and catechola-
mines) is markedly increased with acute exercise.
However, in this study CRP levels were not raised
after maximal exercise in healthy subjects nor in
COPD patients. This finding is unexpected when one
considers data from Rabinovich et al.4 showing
raised levels of TNF alpha and Interleukin 6 (IL-6)
after moderate intensity exercise in COPD patients.
In healthy subjects IL-6 is the predominant cytokine
released from muscle during exercise. IL-6 in turn
appears to be the primary driver for CRP and is
involved with regulation of TNF alpha with the
effect of lowering TNF alpha via the presence of
IL-1ra.5 Furthermore relationships between CRP
and IL-6 have been demonstrated.6
The role of IL-6 seems so important in exercise in
healthy subjects it has been termed the exercise
‘‘work factor’’ and is considered by our group to be
a ‘‘fatigueogen’’ due to its impact on fatigue.7 We
propose, in COPD, that elevated IL-6 concentra-
tions may contribute to the early onset of fatigue
and or breathlessness experienced during physical
exercise.6
There is much debate concerning the type of
muscle work, eccentric or concentric, and exer-
cise, maximal or sub-maximal that provokes the
greatest production of IL-6 but it is apparent that
IL-6 increases exponentially with duration and
intensity of exercise.5 van Helvoort et al. assessed
levels of muscle damage after exercise and foundee front matter & 2006 Elsevier Ltd. All rights reserv
med.2006.02.021no evidence of such. It should be noted however,
that in healthy subjects there is now strong
evidence that IL-6 is produced locally by working
skeletal muscle in the absence of muscle trauma
and this fully accounts for the exercise-induced
increase in plasma IL-6.8 We suggest that a one off
bout of maximal exercise in COPD patients is
insufficient to trigger an acute elevated cytokine
response but that more prolonged endurance-type
exercise may do so. We, like van Helvoort et al.,
agree this is an important area of work and
recommend further studies are designed to define
the exercise-induced cytokine response in COPD
patients during different exercise strategies and
modalities.Reference
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